Search research articles
Contact Us
Filters
Showing results (41-50 of 114) with videos related to
Page
of 12
Sort By:
Controlled Clinical Trials
|
March 1, 1988
Can categorization of patient background problems be used to determine early termination in a clinical trial?
J A Cramer, J F Collins, R H Mattson
Diabetes Technology & Therapeutics
|
February 3, 2005
Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System
J A Cramer, J Okikawa, S Bellaire, et al.
Archives of Internal Medicine
|
July 1, 1990
Compliance declines between clinic visits
J A Cramer, R D Scheyer, R H Mattson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1973
Heroin metabolism in the rat
G L Cohn, J A Cramer, H D Kleber
Therapeutic Drug Monitoring
|
January 1, 1982
Interaction between valproic acid and carbamazepine: an in vitro study of protein binding
G F Mattson, R H Mattson, J A Cramer
Biochimica Et Biophysica Acta
|
January 25, 1980
Reversible trifluoroacetic acid-induced conformational changes in glycophorin A as detected by proton nuclear magnetic resonance spectroscopy
J A Cramer, V T Marchesi, I M Armitage
Journal of Pharmaceutical and Biomedical Analysis
|
March 29, 2001
Comparison of manual protein precipitation (PPT) versus a new small volume PPT 96-well filter plate to decrease sample preparation time
R E Walter, J A Cramer, F L Tse
Clinical Chemistry
|
July 1, 1983
Free fraction of valproic acid is the same in serum and plasma
J A Cramer, K A McCarthy, R H Mattson
Biophysical Journal
|
June 1, 1979
Nuclear magnetic resonance determinations of permeation coefficients for maleic acid in phospholipid vesicles
J H Prestegard, J A Cramer, D B Viscio
Journal of Pharmaceutical Sciences
|
April 1, 1994
A pharmacodynamic approach to the estimate of carbamazepine autoinduction
R D Scheyer, J A Cramer, R H Mattson
Page
of 12
Search research articles
Search
Showing results (41-50 of 114) with videos related to
Sort By:
Page
of 12
Controlled Clinical Trials
|
March 1, 1988
Can categorization of patient background problems be used to determine early termination in a clinical trial?
J A Cramer, J F Collins, R H Mattson
Diabetes Technology & Therapeutics
|
February 3, 2005
Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System
J A Cramer, J Okikawa, S Bellaire, et al.
Archives of Internal Medicine
|
July 1, 1990
Compliance declines between clinic visits
J A Cramer, R D Scheyer, R H Mattson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1973
Heroin metabolism in the rat
G L Cohn, J A Cramer, H D Kleber
Therapeutic Drug Monitoring
|
January 1, 1982
Interaction between valproic acid and carbamazepine: an in vitro study of protein binding
G F Mattson, R H Mattson, J A Cramer
Biochimica Et Biophysica Acta
|
January 25, 1980
Reversible trifluoroacetic acid-induced conformational changes in glycophorin A as detected by proton nuclear magnetic resonance spectroscopy
J A Cramer, V T Marchesi, I M Armitage
Journal of Pharmaceutical and Biomedical Analysis
|
March 29, 2001
Comparison of manual protein precipitation (PPT) versus a new small volume PPT 96-well filter plate to decrease sample preparation time
R E Walter, J A Cramer, F L Tse
Clinical Chemistry
|
July 1, 1983
Free fraction of valproic acid is the same in serum and plasma
J A Cramer, K A McCarthy, R H Mattson
Biophysical Journal
|
June 1, 1979
Nuclear magnetic resonance determinations of permeation coefficients for maleic acid in phospholipid vesicles
J H Prestegard, J A Cramer, D B Viscio
Journal of Pharmaceutical Sciences
|
April 1, 1994
A pharmacodynamic approach to the estimate of carbamazepine autoinduction
R D Scheyer, J A Cramer, R H Mattson
Page
of 12